ImmuneAGE is a company headquartered in the United States.
ImmuneAGE develops longevity biotech innovations focused on the biology of aging and immune system rejuvenation to extend healthy human lifespan.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.